University of Cambridge > Talks.cam > Cancer Research UK Cambridge Centre Lectures in Cancer Biology and Medicine > The AKT inhibitor capivasertib (AZD5363): from discovery to clinical proof concept

  Browse A-Z

Log in

Cambridge users (raven)details Other usersdetails No account?details

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

The AKT inhibitor capivasertib (AZD5363): from discovery to clinical proof concept

Add to your list(s) Download to your calendar using vCal

  • UserDr Barry Davies, Director, Clinical Translation Scientific Alliances, AstraZeneca
  • ClockThursday 11 February 2021, 09:30-10:30
  • HouseOnline - Google Meet as below.

If you have a question about this talk, please contact Justin Holt.

Link to live lecture: https://meet.google.com/dji-ktvq-ezz

This talk is part of the Cancer Research UK Cambridge Centre Lectures in Cancer Biology and Medicine series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Cambridge Migration Society Type the title of a new list here King's Review

Other talks

Science & Engineering An analytic model of a star cluster evolution in a galactic tidal field ONLINE WEBINAR - Aircraft Electrification CERF in the (virtual) City 2021 Seismic soil-pile-structure interaction in soft clays and layered soils
 

© 2006-2024 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity